The Limits of Statins: Uncovering Treatment Options for Heart Valve Disease

Heart disease remains a leading cause of mortality worldwide, and within this category, valvular heart disease (VHD) presents a significant challenge. While statins have revolutionized cholesterol management and reduced the risk of atherosclerotic cardiovascular disease (ASCVD), their impact on VHD is limited. This article explores the limitations of statins in treating VHD and delves into alternative treatment options offering a more comprehensive approach to managing this condition. Understanding Valvular Heart Disease VHD encompasses a spectrum of conditions affecting the heart's valves, compromising their ability to function properly. These valves ensure unidirectional blood flow within the heart chambers and prevent backflow. When a valve narrows (stenosis), leaks (regurgitation), or fails to close completely (prolapse), blood flow is disrupted, leading to various complications.